IANS Year Ender 2025: Anti-obesity drive, generic drugs to remain key focus in 2026
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi's clarion call, obesity became the focus of healthcare in India in 2025.